alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4121 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 623
117th CONGRESS
  2d Session
                                S. 4121

                          [Report No. 117-246]

 To designate the Kol Israel Foundation Holocaust Memorial in Bedford 
                 Heights, Ohio, as a national memorial.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 28, 2022

Mr. Brown (for himself and Mr. Portman) introduced the following bill; 
   which was read twice and referred to the Committee on Energy and 
                           Natural Resources

                           December 12, 2022

               Reported by Mr. Manchin, without amendment

_______________________________________________________________________

                                 A BILL

 
 To designate the Kol Israel Foundation Holocaust Memorial in Bedford 
                 Heights, Ohio, as a national memorial.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION OF THE KOL ISRAEL FOUNDATION HOLOCAUST MEMORIAL 
              AS A NATIONAL MEMORIAL.

    (a) Congressional Recognition.--Congress--
            (1) recognizes the significance of the Kol Israel 
        Foundation Holocaust Memorial in preserving the memory of the 
        6,000,000 Jews murdered by the Nazi regime and allies and 
        collaborators of the Nazi regime; and
            (2) honors the life and legacy of the Holocaust survivors 
        who erected the Kol Israel Foundation Holocaust Memorial.
    (b) Designation.--
            (1) In general.--The Kol Israel Foundation Holocaust 
        Memorial located in Bedford Heights, Ohio, is designated as a 
        national memorial.
            (2) Effect of designation.--
                    (A) In general.--The national memorial designated 
                by paragraph (1) is not a unit of the National Park 
                System.
                    (B) Use of federal funds.--The designation of the 
                national memorial by paragraph (1) shall not require or 
                permit Federal funds to be expended for any purpose 
                relating to the national memorial.
                                                       Calendar No. 623

117th CONGRESS

  2d Session

                                S. 4121

                          [Report No. 117-246]

_______________________________________________________________________

                                 A BILL

 To designate the Kol Israel Foundation Holocaust Memorial in Bedford 
                 Heights, Ohio, as a national memorial.

_______________________________________________________________________

                           December 12, 2022

                       Reported without amendment
```
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 19, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-10406

American Mitsuba Corporation:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request concerns a product strategically important or related to 

‘‘Made in China 2025’’ or other Chinese industrial programs.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-2588

Primex Family of Companies:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
Computation of Earnings Per Share


                                                  Year Ended December 31
                                             1996         1995           1994
                                          -----------   ----------    ----------

Primary:
  Average Shares Outstanding               14,317,465   15,039,179    15,480,368
  Net effect of dilutive stock options -
   based on the treasury stock method
   using average market price                 200,306      252,649       347,892
                                              -------      -------       -------

  Total                                    14,517,771   15,291,828    15,828,260
                                           ==========   ==========    ==========

  Net Income                             $ 32,953,000  $ 40,455,00   $ 8,182,000
                                         ============  ===========   ===========

  Per Share Amount                             $ 2.27      $ 2.65         $ 0.52
                                               ======      ======         ======

Fully Diluted:
  Average Shares Outstanding               14,317,465   15,039,179    15,480,368
  Net effect of dilutive stock options -
    based on the treasury stock method
    using the year-end market price, if
    higher than average market price          200,977      271,235       348,642
                                              -------      -------       -------

 Total                                     14,518,442   15,310,414    15,829,010
                                           ==========   ==========    ==========

 Net Income                              $ 32,953,000  $ 40,455,00   $ 8,182,000
                                         ============  ===========   ===========

 Per Share Amount                              $ 2.27       $ 2.64        $ 0.52
                                               ======       ======        ======
<PAGE>
[Federal Register Volume 60, Number 49 (Tuesday, March 14, 1995)]
[Notices]
[Page 13736]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6221]



[[Page 13736]]

DEPARTMENT OF JUSTICE


Importation of Controlled Substances; Notice of Application

    Pursuant to Section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under Section 1002(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Section 1311.42 of Title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on February 2, 
1995, Roche Diagnostic System, Inc., 1080 U.S. Highway 202, Somerville, 
New Jersey 08876, made application to the Drug Enforcement 
Administration to be registered as an importer of Tetrahydrocannabinols 
(7370) a basic class of controlled substance in Schedule I.
    The Tetrahydrocannabinols will be utilized exclusively for non-
human consumption in drug of abuse detection kits.
    Any manufacturer holding, or applying for, registration as a bulk 
manufacturer of this basic class of controlled substance may file 
written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.54 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than April 13, 1995.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1311.42 (b), (c), 
(d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 
(September 23, 1975), all applicants for registration to import a basic 
class of any controlled substance in Schedule I or II are and will 
continue to be required to demonstrate to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration that the requirements for such registration pursuant to 
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c), 
(d), (e), and (f) are satisfied.

    Dated: March 8, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Division Control, Drug 
Enforcement Administration.
[FR Doc. 95-6221 Filed 3-13-95; 8:45 am]
BILLING CODE 4410-09-M
[Federal Register Volume 60, Number 64 (Tuesday, April 4, 1995)]
[Sunshine Act Meetings]
[Page 17096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6264]



-----------------------------------------------------------------------


Equal Employment Opportunity Commission

DATE AND TIME: April 25, 1995, 2:00 p.m. (Eastern Time).

PLACE: Conference Room on the Ninth Floor of the EEOC Office Building, 
1801 ``L'' Street, N.W., Washington, D.C. 20507.

STATUS: The Meeting will be open to the public.

MATTERS TO BE CONSIDERED:

Open Session

    1. Recommendations on Alternative Dispute Resolution will be 
heard by the Commission.

    Note: Any matter discussed or concluded may be carried over to a 
later meeting. (In addition to publishing notices on EEOC Commission 
meetings in the Federal Register, the Commission also provides a 
recorded announcement a full week in advance on future Commission 
sessions.) Please telephone (202) 663-7100 (voice) and (202) 663-
4074 (TDD) at any time for information on these meetings.

CONTACT PERSON FOR MORE INFORMATION: Frances M. Hart, Executive Officer 
on (202) 663-4070.

    This Notice issued March 30, 1995.
Frances M. Hart,
Executive Officer, Executive Secretariat.
[FR Doc. 95-6264 Filed 3-30-95; 4:23 pm]
BILLING CODE 6750-06-M
II 

117TH CONGRESS 

2D SESSION S. 4135 

To dissolve the Department of Homeland Security Disinformation Governance 

Board, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

MAY 4, 2022 

Mr. HAWLEY introduced the following bill; which was read twice and referred 

to the Committee on Homeland Security and Governmental Affairs 

A BILL 

To dissolve the Department of Homeland Security 

Disinformation Governance Board, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Dissolving the 

5 Disinformation Governance Board Act’’. 

6 SEC. 2. SENSE OF CONGRESS. 

7 It is the sense of Congress that the Department of 

8 Homeland Security Disinformation Governance Board is 

9 unconstitutional and should be dissolved immediately. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 4135 IS

1 SEC. 3. DEFINITIONS. 

2 In this Act: 

3 (1) BOARD.—The term ‘‘Board’’ means the 

4 Disinformation Governance Board. 

5 (2) SECRETARY.—The term ‘‘Secretary’’ means 

6 the Secretary of Homeland Security. 

7 SEC. 4. DISSOLUTION. 

8 (a) IN GENERAL.—The Board is hereby dissolved. 

9 (b) REMOVAL OF EXECUTIVE DIRECTOR.—The Sec10 retary shall immediately remove the Executive Director 

11 from the Board. 

12 (c) FUNDING RESTRICTION.—Beginning on the date 

13 of the enactment of this Act, no Federal funds may be 

14 used for the operation of the Board. 

15 SEC. 5. NO SUCCESSOR ENTITIES OR ACTIVITIES. 

16 The Secretary may not— 

17 (1) establish any entity equivalent to the Board; 

18 or 

19 (2) authorize activities at the Department of 

20 Homeland Security that are substantially similar to 

21 the activities of the Board. 

22 SEC. 6. DISCLOSURE. 

23 Not later than 30 days after the date of the enact24 ment of this Act, the Secretary shall submit to the Com25 mittee on Homeland Security and Governmental Affairs 


kjohnson on DSK79L0C42PROD with BILLS
3 

•S 4135 IS

1 of the Senate and the Committee on Homeland Security 

2 of the House of Representatives— 

3 (1) a report describing the formation of the 

4 Board; and 

5 (2) all of the records in the possession of the 

6 Department of Homeland Security related to the 

7 Board, including— 

8 (A) written or recorded communications 

9 concerning the formation of the Board; 

10 (B) the agenda or minutes from any meet11 ing at which the Board’s formation was dis12 cussed; 

13 (C) any legal review to determine whether 

14 the activities of the Board would be authorized 

15 by the Constitution of the United States; 

16 (D) any communications or records about 

17 the individuals who would be recruited to serve 

18 on the Board; and 

19 (E) any communications concerning the 

20 appointment of an executive director for the 

21 Board. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
Exhibit 10.11





OPTION AGREEMENT





This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Brian T. McGee (the "Optionee") pursuant to the Generex Biotechnology Corporation Amended 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference.  The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:





a.           The date of grant of the Option is March 25, 2011, and the number of shares of Company Stock that may be purchased upon exercise of the Option is 200,000.





b.           The purchase price (the “Exercise Price”) of Company Stock subject to the Option is $0.282 per share.





c.           The Option shall become exercisable as follows, subject to the terms, conditions, limitations and restrictions set forth in the Plan:  200,000 shares will vest on March 25, 2011.  Only options that have vested may be exercised.





d.           Unless sooner terminated pursuant to the Plan, the Option shall terminate on March 25, 2016.





e.           The Optionee shall pay the Exercise Price for the Option (i) in cash or (ii) by such other method as may be approved by the Compensation Committee of the Company’s Board of Directors.  The Optionee shall pay the amount of any withholding tax due at the time of exercise, as provided in the Plan.





f.           The rights and interests of the Optionee under this Option Agreement may not be sold, assigned, encumbered or otherwise transferred, except, in the event of the death of the Optionee, by will or by the laws of descent and distribution.





g.           Any notice to the Company, including notice of exercise of an Option, shall be addressed to the Company in care of Mark Fletcher at the Company’s principal offices.





IN WITNESS WHEREOF, this Option Agreement has been executed on behalf of the Company by a duly authorized officer and by the Optionee effective as of the date of grant of the Option.





GENEREX BIOTECHNOLOGY CORPORATION

ACCEPTED AND AGREED:Per:
/s/ Mark A. Fletcher

/s/  Brian T. McGeeBrian T. McGee, OptioneeName:
Mark A. Fletcher,President & CEOPer:
/s/  Stephen FellowsName:
Stephen Fellows,Acting Chief Financial Officer
#### The People of the State of New York, Respondent, v Chris Mohabeer, Appellant.

[774 NYS2d 724]

Appeal by the defendant from an order of the Supreme Court, Richmond County (Rooney, J.), dated June 29, 2001, which, pursuant to Correction Law article 6-C, designated him a level three sex offender.

Ordered that the order is affirmed, without costs or disbursements.

The People presented clear and convincing evidence sufficient to support the Supreme Court’s determination designating the defendant a level three sex offender under the Sex Offender *651Registration Act *(see*Correction Law § 168-n [3]; *People v Hampton,*300 AD2d 641 [2002]; *People v Stores,*300 AD2d 554, 555 [2002]; *People v Wroten,*286 AD2d 189, 199 [2001]).

The defendant’s remaining contention is not properly before this Court. Prudenti, *P.J.,*Smith, Goldstein and Crane, JJ., concur.
[Federal Register Volume 60, Number 46 (Thursday, March 9, 1995)]
[Notices]
[Pages 12938-12939]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-5723]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. RP95-195-000]


Columbia Gulf Transmission Co.; Notice of Proposed Changes in 
FERC Gas Tariff

March 3, 1995.
    Take notice that on March 1, 1995, Columbia Gulf Transmission 
Company (Columbia Gulf), tendered for filing to become part of its FERC 
Gas Tariff, Second Revised Volume No. 1, the following tariff sheets, 
to be effective April 1, 1995:

Fifth Revised Sheet No. 018
Fifth Revised Sheet No. 019

    [[Page 12939]] Columbia Gas states that the instant filing 
represents Columbia Gulf's annual filing pursuant to Section 33, 
Transportation Retainage Adjustment (TRA), of the General Terms and 
Conditions of its FERC Gas Tariff, Second Revised Volume No. 1.
    Columbia Gulf states that it currently has retainage factors for 
each of its three zones. Each factor consists of a current and an 
unrecovered component for company-use, lost, and unaccounted for 
quantities. In this filing, Columbia Gulf is adjusting the current 
component of each retainage factor to reflect a change in the estimate 
for company-use, lost and unaccounted for quantities. The uncovered 
component for each of the retainage factors is also being adjusted in 
this filing to account for an over recovery of these quanties during 
the deferral period.
    Furthermore, Columbia Gulf is requesting a waiver to permit using a 
14-month deferral period in calculating the unrecovered component.
    Columbia Gulf states that copies of its filing have been mailed to 
all firm customers and affected state regulatory commissions.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, North Capitol Street, N.E., Washington, D.C. 
20426, in accordance with Rules 211 and 214 of the Commission's Rules 
of Practice and Procedure. All such motions or protests should be filed 
on or before March 10, 1995. Protests will be considered by the 
Commission in determining the appropriate action to be taken, but will 
not serve to make protestants parties to the proceedings. Any person 
wishing to become a party must file a motion to intervene. Copies of 
Columbia Gulf's filings are on file with the Commission and are 
available for public inspection.
Lois D. Cashell,
Secretary.
[FR Doc. 95-5723 Filed 3-8-95; 8:45 am]
BILLING CODE 6717-01-M
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 4, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-2712

Primex Family of Companies:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
[Federal Register Volume 60, Number 45 (Wednesday, March 8, 1995)]
[Sunshine Act Meetings]
[Page 12823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-5849]





                Sunshine Act Meetings



Federal Register / Vol. 60, No. 45 / Wednesday, March 8, 1995 / 
Sunshine Act Meetings
[[Page 12823]] 




Equal Employment Opportunity Commission

``FEDERAL REGISTER'' CITATION OF PREVIOUS ANNOUNCEMENT: 60 Fed. Reg. 
12032, March 3, 1995.

PREVIOUSLY ANNOUNCED TIME AND DATE OF MEETING: 2:00 p.m. (Eastern Time) 
March 14, 1995.

CHANGE IN THE MEETING:

Closed Session

    The closed session of the meeting has been cancelled.

CONTACT PERSON FOR MORE INFORMATION: Frances M. Hart, Executive Officer 
on (202) 663-4070.

    Dated: March 6, 1995.
Frances M. Hart,

Executive Officer, Executive Secretariat.

[FR Doc. 95-5849 Filed 3-6-95; 3:51 pm]

BILLING CODE 6750-06-M